SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001140361-24-017676
Filing Date
2024-04-03
Accepted
2024-04-03 17:27:47
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM S-3 ny20010746x1_s3.htm S-3 594386
2 EXHIBIT 4.3 ny20010746x1_ex4-3.htm EX-4.3 398654
3 EXHIBIT 5.1 ny20010746x1_ex5-1.htm EX-5.1 30133
4 EXHIBIT 5.2 ny20010746x1_ex5-2.htm EX-5.2 13987
5 EXHIBIT 23.1 ny20010746x1_ex23-1.htm EX-23.1 1414
6 EXHIBIT 107 ny20010746x1_ex107.htm EX-FILING FEES 40065
7 logo_aquestivex1.jpg GRAPHIC 26566
8 ny20010746x1_logo01.jpg GRAPHIC 2382
  Complete submission text file 0001140361-24-017676.txt   1119567
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-278498 | Film No.: 24820252
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)